Copyright Reports & Markets. All rights reserved.

Global Mesalazine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Purity
    • 1.3.1 Overview: Global Mesalazine Consumption Value by Purity: 2019 Versus 2023 Versus 2030
    • 1.3.2 Above 97 %
    • 1.3.3 Above 98 %
    • 1.3.4 Above 99 %
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Mesalazine Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Tablets
    • 1.4.3 Capsules
    • 1.4.4 Pellet and Granule
    • 1.4.5 Suppository
    • 1.4.6 Enema
    • 1.4.7 Others
  • 1.5 Global Mesalazine Market Size & Forecast
    • 1.5.1 Global Mesalazine Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Mesalazine Sales Quantity (2019-2030)
    • 1.5.3 Global Mesalazine Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 PharmaZell
    • 2.1.1 PharmaZell Details
    • 2.1.2 PharmaZell Major Business
    • 2.1.3 PharmaZell Mesalazine Product and Services
    • 2.1.4 PharmaZell Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 PharmaZell Recent Developments/Updates
  • 2.2 Syntese A/S
    • 2.2.1 Syntese A/S Details
    • 2.2.2 Syntese A/S Major Business
    • 2.2.3 Syntese A/S Mesalazine Product and Services
    • 2.2.4 Syntese A/S Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Syntese A/S Recent Developments/Updates
  • 2.3 Cambrex Corporation
    • 2.3.1 Cambrex Corporation Details
    • 2.3.2 Cambrex Corporation Major Business
    • 2.3.3 Cambrex Corporation Mesalazine Product and Services
    • 2.3.4 Cambrex Corporation Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Cambrex Corporation Recent Developments/Updates
  • 2.4 Divis Laboratories
    • 2.4.1 Divis Laboratories Details
    • 2.4.2 Divis Laboratories Major Business
    • 2.4.3 Divis Laboratories Mesalazine Product and Services
    • 2.4.4 Divis Laboratories Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Divis Laboratories Recent Developments/Updates
  • 2.5 Chemi SpA
    • 2.5.1 Chemi SpA Details
    • 2.5.2 Chemi SpA Major Business
    • 2.5.3 Chemi SpA Mesalazine Product and Services
    • 2.5.4 Chemi SpA Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Chemi SpA Recent Developments/Updates
  • 2.6 Ipca Laboratories
    • 2.6.1 Ipca Laboratories Details
    • 2.6.2 Ipca Laboratories Major Business
    • 2.6.3 Ipca Laboratories Mesalazine Product and Services
    • 2.6.4 Ipca Laboratories Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Ipca Laboratories Recent Developments/Updates
  • 2.7 Hangzhou Brother
    • 2.7.1 Hangzhou Brother Details
    • 2.7.2 Hangzhou Brother Major Business
    • 2.7.3 Hangzhou Brother Mesalazine Product and Services
    • 2.7.4 Hangzhou Brother Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Hangzhou Brother Recent Developments/Updates
  • 2.8 Lianyungang Fengheng Biopharm
    • 2.8.1 Lianyungang Fengheng Biopharm Details
    • 2.8.2 Lianyungang Fengheng Biopharm Major Business
    • 2.8.3 Lianyungang Fengheng Biopharm Mesalazine Product and Services
    • 2.8.4 Lianyungang Fengheng Biopharm Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
  • 2.9 Lasa Loboratory
    • 2.9.1 Lasa Loboratory Details
    • 2.9.2 Lasa Loboratory Major Business
    • 2.9.3 Lasa Loboratory Mesalazine Product and Services
    • 2.9.4 Lasa Loboratory Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Lasa Loboratory Recent Developments/Updates
  • 2.10 Corden Pharma Bergamo
    • 2.10.1 Corden Pharma Bergamo Details
    • 2.10.2 Corden Pharma Bergamo Major Business
    • 2.10.3 Corden Pharma Bergamo Mesalazine Product and Services
    • 2.10.4 Corden Pharma Bergamo Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Corden Pharma Bergamo Recent Developments/Updates
  • 2.11 Erregierre SpA
    • 2.11.1 Erregierre SpA Details
    • 2.11.2 Erregierre SpA Major Business
    • 2.11.3 Erregierre SpA Mesalazine Product and Services
    • 2.11.4 Erregierre SpA Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Erregierre SpA Recent Developments/Updates
  • 2.12 CTX Lifescience
    • 2.12.1 CTX Lifescience Details
    • 2.12.2 CTX Lifescience Major Business
    • 2.12.3 CTX Lifescience Mesalazine Product and Services
    • 2.12.4 CTX Lifescience Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 CTX Lifescience Recent Developments/Updates
  • 2.13 Ishita Active Pharma Ingredients
    • 2.13.1 Ishita Active Pharma Ingredients Details
    • 2.13.2 Ishita Active Pharma Ingredients Major Business
    • 2.13.3 Ishita Active Pharma Ingredients Mesalazine Product and Services
    • 2.13.4 Ishita Active Pharma Ingredients Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
  • 2.14 YC Biotech (Jiangsu)
    • 2.14.1 YC Biotech (Jiangsu) Details
    • 2.14.2 YC Biotech (Jiangsu) Major Business
    • 2.14.3 YC Biotech (Jiangsu) Mesalazine Product and Services
    • 2.14.4 YC Biotech (Jiangsu) Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
  • 2.15 Xinxiang Tianfeng Fine Chemical
    • 2.15.1 Xinxiang Tianfeng Fine Chemical Details
    • 2.15.2 Xinxiang Tianfeng Fine Chemical Major Business
    • 2.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Product and Services
    • 2.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates

3 Competitive Environment: Mesalazine by Manufacturer

  • 3.1 Global Mesalazine Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Mesalazine Revenue by Manufacturer (2019-2024)
  • 3.3 Global Mesalazine Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Mesalazine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Mesalazine Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Mesalazine Manufacturer Market Share in 2023
  • 3.5 Mesalazine Market: Overall Company Footprint Analysis
    • 3.5.1 Mesalazine Market: Region Footprint
    • 3.5.2 Mesalazine Market: Company Product Type Footprint
    • 3.5.3 Mesalazine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Mesalazine Market Size by Region
    • 4.1.1 Global Mesalazine Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Mesalazine Consumption Value by Region (2019-2030)
    • 4.1.3 Global Mesalazine Average Price by Region (2019-2030)
  • 4.2 North America Mesalazine Consumption Value (2019-2030)
  • 4.3 Europe Mesalazine Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Mesalazine Consumption Value (2019-2030)
  • 4.5 South America Mesalazine Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Mesalazine Consumption Value (2019-2030)

5 Market Segment by Purity

  • 5.1 Global Mesalazine Sales Quantity by Purity (2019-2030)
  • 5.2 Global Mesalazine Consumption Value by Purity (2019-2030)
  • 5.3 Global Mesalazine Average Price by Purity (2019-2030)

6 Market Segment by Application

  • 6.1 Global Mesalazine Sales Quantity by Application (2019-2030)
  • 6.2 Global Mesalazine Consumption Value by Application (2019-2030)
  • 6.3 Global Mesalazine Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Mesalazine Sales Quantity by Purity (2019-2030)
  • 7.2 North America Mesalazine Sales Quantity by Application (2019-2030)
  • 7.3 North America Mesalazine Market Size by Country
    • 7.3.1 North America Mesalazine Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Mesalazine Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Mesalazine Sales Quantity by Purity (2019-2030)
  • 8.2 Europe Mesalazine Sales Quantity by Application (2019-2030)
  • 8.3 Europe Mesalazine Market Size by Country
    • 8.3.1 Europe Mesalazine Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Mesalazine Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Mesalazine Sales Quantity by Purity (2019-2030)
  • 9.2 Asia-Pacific Mesalazine Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Mesalazine Market Size by Region
    • 9.3.1 Asia-Pacific Mesalazine Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Mesalazine Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Mesalazine Sales Quantity by Purity (2019-2030)
  • 10.2 South America Mesalazine Sales Quantity by Application (2019-2030)
  • 10.3 South America Mesalazine Market Size by Country
    • 10.3.1 South America Mesalazine Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Mesalazine Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Mesalazine Sales Quantity by Purity (2019-2030)
  • 11.2 Middle East & Africa Mesalazine Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Mesalazine Market Size by Country
    • 11.3.1 Middle East & Africa Mesalazine Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Mesalazine Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Mesalazine Market Drivers
  • 12.2 Mesalazine Market Restraints
  • 12.3 Mesalazine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Mesalazine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Mesalazine
  • 13.3 Mesalazine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Mesalazine Typical Distributors
  • 14.3 Mesalazine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn"s disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
    According to our (Global Info Research) latest study, the global Mesalazine market size was valued at US$ 185 million in 2023 and is forecast to a readjusted size of USD 236 million by 2030 with a CAGR of 3.6% during review period.
    Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
    This report is a detailed and comprehensive analysis for global Mesalazine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Purity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Mesalazine market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
    Global Mesalazine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
    Global Mesalazine market size and forecasts, by Purity and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
    Global Mesalazine market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Mesalazine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Mesalazine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Mesalazine market is split by Purity and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Purity
    Above 97 %
    Above 98 %
    Above 99 %
    Market segment by Application
    Tablets
    Capsules
    Pellet and Granule
    Suppository
    Enema
    Others
    Major players covered
    PharmaZell
    Syntese A/S
    Cambrex Corporation
    Divis Laboratories
    Chemi SpA
    Ipca Laboratories
    Hangzhou Brother
    Lianyungang Fengheng Biopharm
    Lasa Loboratory
    Corden Pharma Bergamo
    Erregierre SpA
    CTX Lifescience
    Ishita Active Pharma Ingredients
    YC Biotech (Jiangsu)
    Xinxiang Tianfeng Fine Chemical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Mesalazine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Mesalazine, with price, sales quantity, revenue, and global market share of Mesalazine from 2019 to 2024.
    Chapter 3, the Mesalazine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Mesalazine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Purity and by Application, with sales market share and growth rate by Purity, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Mesalazine market forecast, by regions, by Purity, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Mesalazine.
    Chapter 14 and 15, to describe Mesalazine sales channel, distributors, customers, research findings and conclusion.

    Buy now